CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-06 | Attar Eyal C. CHIEF MEDICAL OFFICER | Shares withheld for taxes | −1,180 | $1.50 | $2K | 131,406 |
| 2025-02-03 | ANG ROBERT PRESIDENT AND CEO | Shares withheld for taxes | −3,248 | $1.34 | $4K | 784,239 |
| 2025-02-03 | ANG ROBERT PRESIDENT AND CEO | Grant or award | +137,500 | 921,739 | ||
| 2025-02-03 | ANG ROBERT PRESIDENT AND CEO | Returned to the company · Employee Stock Option (right to buy) | −147,294 | 0 | ||
| 2025-02-03 | ANG ROBERT PRESIDENT AND CEO | Grant or award · Employee Stock Option (right to buy) | +147,294 | 147,294 | ||
| 2025-02-03 | ANG ROBERT PRESIDENT AND CEO | Returned to the company · Employee Stock Option (right to buy) | −652,086 | 0 | ||
| 2025-02-03 | ANG ROBERT PRESIDENT AND CEO | Grant or award · Employee Stock Option (right to buy) | +652,086 | 652,086 | ||
| 2025-02-03 | ANG ROBERT PRESIDENT AND CEO | Returned to the company · Employee Stock Option (right to buy) | −51,060 | 0 | ||
| 2025-02-03 | ANG ROBERT PRESIDENT AND CEO | Grant or award · Employee Stock Option (right to buy) | +51,060 | 51,060 | ||
| 2025-02-03 | ANG ROBERT PRESIDENT AND CEO | Returned to the company · Employee Stock Option (right to buy) | −376,000 | 0 | ||
| 2025-02-03 | ANG ROBERT PRESIDENT AND CEO | Grant or award · Employee Stock Option (right to buy) | +376,000 | 376,000 | ||
| 2025-02-03 | ANG ROBERT PRESIDENT AND CEO | Returned to the company · Employee Stock Option (right to buy) | −172,500 | 0 | ||
| 2025-02-03 | ANG ROBERT PRESIDENT AND CEO | Grant or award · Employee Stock Option (right to buy) | +172,500 | 172,500 | ||
| 2025-02-03 | ANG ROBERT PRESIDENT AND CEO | Returned to the company · Employee Stock Option (right to buy) | −257,500 | 0 | ||
| 2025-02-03 | ANG ROBERT PRESIDENT AND CEO | Grant or award · Employee Stock Option (right to buy) | +257,500 | 257,500 | ||
| 2025-02-03 | ANG ROBERT PRESIDENT AND CEO | Returned to the company · Employee Stock Option (right to buy) | −470,000 | 0 | ||
| 2025-02-03 | ANG ROBERT PRESIDENT AND CEO | Grant or award · Employee Stock Option (right to buy) | +470,000 | 470,000 | ||
| 2025-02-03 | ANG ROBERT PRESIDENT AND CEO | Grant or award · Employee Stock Option (right to buy) | +825,000 | 825,000 | ||
| 2025-02-03 | Chakraborty Tirtha CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −1,163 | $1.34 | $2K | 168,772 |
| 2025-02-03 | Chakraborty Tirtha CHIEF SCIENTIFIC OFFICER | Grant or award | +52,500 | 221,272 |
Page 8 of 18 · 344 trades